ANA (Anti-Nuclear Antibodies) ELISA testing, integrated within the Healthesh system, is a diagnostic procedure used to detect the presence of autoantibodies directed against components of the cell nucleus. These antibodies are associated with autoimmune diseases such as systemic lupus erythematosus (SLE), Sjögren’s syndrome, rheumatoid arthritis, and systemic sclerosis.

The ANA ELISA test is performed on blood samples, and it measures the levels of autoantibodies targeting nuclear antigens. Results are reported as titers, indicating the dilution of the patient’s serum where antibodies are still detectable. Higher titers are often associated with more severe autoimmune diseases, though titers alone do not provide a definitive diagnosis and must be interpreted alongside clinical symptoms and other diagnostic tests.

Integrating ANA ELISA testing within the Healthesh system allows for efficient analysis and interpretation of results, aiding healthcare professionals in diagnosing and managing autoimmune diseases effectively. This comprehensive approach to autoantibody testing contributes to improved patient care and outcomes.